AssureRx, LLC, based in Cincinnati, was founded in 2006 through a joint investment of Queen City Angels, CincyTech, Blue Chip Venture Co., Cincinnati Children's Hospital Medical Center Tomorrow Fund, Ohio Tech Angels, DHC Tech and private investors. The company, formed to license and commercialize personalized medicine technology research from Cincinnati Children's Hospital Medical Center and Mayo Clinic, is now developing the next generation of medicines, including a lab-developed test that will measure and analyze genetic variants in psychiatric medicine. The test will help doctors determine the appropriate drug and dosage for each patient's individual needs, which could lessen side effects in patients taking them. The test is based on pharmacogenetics, or the study of how a person's genetic makeup influences their body's reaction to drug treatments.